Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences

[1]  S. Maier,et al.  Evidence that opioids may have toll-like receptor 4 and MD-2 effects , 2010, Brain, Behavior, and Immunity.

[2]  Mark R Hutchinson,et al.  The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. , 2009, Trends in pharmacological sciences.

[3]  Sara Fernández-Lizarbe,et al.  Critical Role of TLR4 Response in the Activation of Microglia Induced by Ethanol1 , 2009, The Journal of Immunology.

[4]  Hayyoung Lee,et al.  The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex , 2009, Nature.

[5]  S. Maier,et al.  Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia , 2008, Brain, Behavior, and Immunity.

[6]  S. Maier,et al.  Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia , 2008, Brain, Behavior, and Immunity.

[7]  S. Maier,et al.  Non‐stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll‐like receptor 4 (TLR4) , 2008, The European journal of neuroscience.

[8]  Kirk W. Johnson,et al.  Opioid-Induced Glial Activation: Mechanisms of Activation and Implications for Opioid Analgesia, Dependence, and Reward , 2007, TheScientificWorldJournal.

[9]  L. Tseng,et al.  p38 mitogen-activated protein kinase inhibitor SB203580 reverses the antianalgesia induced by dextro-morphine or morphine in the mouse spinal cord. , 2006, European journal of pharmacology.

[10]  Hidetoshi Shimodaira,et al.  Pvclust: an R package for assessing the uncertainty in hierarchical clustering , 2006, Bioinform..

[11]  I. Sora,et al.  Dextro- and levo-morphine attenuate opioid δ and κ receptor agonist produced analgesia in μ-opioid receptor knockout mice , 2006 .

[12]  Jian-qiang Feng,et al.  Activation of p38 mitogen-activated protein kinase in spinal microglia mediates morphine antinociceptive tolerance , 2006, Brain Research.

[13]  M. Shibasaki,et al.  Direct Evidence of Astrocytic Modulation in the Development of Rewarding Effects Induced by Drugs of Abuse , 2006, Neuropsychopharmacology.

[14]  L. Tseng,et al.  Antianalgesia: Stereoselective Action of dextro-Morphine over levo-Morphine on Glia in the Mouse Spinal Cord , 2005, Journal of Pharmacology and Experimental Therapeutics.

[15]  I. Goshen,et al.  Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance , 2005, Pain.

[16]  J. Deleo,et al.  The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Nath,et al.  Synergistic increases in intracellular Ca2+, and the release of MCP‐1, RANTES, and IL‐6 by astrocytes treated with opiates and HIV‐1 Tat , 2005, Glia.

[18]  K. Murayama,et al.  A Tyr-W-MIF-1 Analog Containing D-Pro2 Acts as a Selective μ2-Opioid Receptor Antagonist in the Mouse , 2005, Journal of Pharmacology and Experimental Therapeutics.

[19]  H. Ueda,et al.  Morphine-Induced Chemotaxis and Brain-Derived Neurotrophic Factor Expression in Microglia , 2005, The Journal of Neuroscience.

[20]  S. Maier,et al.  A Role for Proinflammatory Cytokines and Fractalkine in Analgesia, Tolerance, and Subsequent Pain Facilitation Induced by Chronic Intrathecal Morphine , 2004, The Journal of Neuroscience.

[21]  J. Deleo,et al.  Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain , 2004, Neurochemistry International.

[22]  J. Deleo,et al.  Complete Freunds adjuvant‐induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS , 2004, The European journal of neuroscience.

[23]  S. Maier,et al.  Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120 , 2000, Brain Research.

[24]  S. Maier,et al.  A method for increasing the viability of the external portion of lumbar catheters placed in the spinal subarachnoid space of rats , 1999, Journal of Neuroscience Methods.

[25]  P. Peterson,et al.  Morphine enhances complement receptor-mediated phagocytosis of Cryptococcus neoformans by human microglia. , 1998, Clinical immunology and immunopathology.

[26]  G. Stefano Autoimmunovascular regulation: morphine and ancondamide and ancondamide stimulated nitric oxide release , 1998, Journal of Neuroimmunology.

[27]  T. Molitor,et al.  The opioid–cytokine connection , 1998, Journal of Neuroimmunology.

[28]  H. Gutstein The effects of pain on opioid tolerance: how do we resolve the controversy? , 1996, Pharmacological reviews.

[29]  G. Fricchione,et al.  Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. , 1996, Journal of immunology.

[30]  J. Carmody Avoiding fallacies in nociceptive measurements , 1995, Pain.

[31]  R. Shank,et al.  Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. , 1995, The Journal of pharmacology and experimental therapeutics.

[32]  G. Stefano,et al.  Occurrence of the opiate alkaloid-selective μ3 receptor in mammalian microglia, astrocytes and Kupffer cells , 1995, Brain Research.

[33]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[34]  M. Tsang,et al.  Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression. , 1994, The Journal of pharmacology and experimental therapeutics.

[35]  R. Dubner,et al.  A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia , 1987, Pain.

[36]  Lewis O. Harvey,et al.  Efficient estimation of sensory thresholds , 1986 .

[37]  T. Appelboom,et al.  Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. , 1979, Journal of immunology.

[38]  K. Rice,et al.  Stereospecific and nonstereospecific effects of (+)- and (-)-morphine: evidence for a new class of receptors? , 1977, Science.

[39]  H. Strasburger,et al.  Fitting the psychometric function , 1999, Perception & psychophysics.

[40]  L. Christrup,et al.  The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. , 1995, Life sciences.

[41]  D. A. Kenny,et al.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. , 1986, Journal of personality and social psychology.